Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×

watch

Orexigen Therapeutics, Inc.

Sector: Pharmaceutical Preparations Region: CA, United States


Exchange/Ticker: Nasdaq: OREX


Company Description

Orexigen Therapeutics, Inc. is a biopharmaceutical company engaged in the development of pharmaceutical product candidates for the treatment of obesity. Its two lead products are Contrave, which is a weight loss medication for the management of obesity and Empatic, which is an immediate release formulation, approved for the adjunctive treatment of partial seizures, a form of epilepsy. Orexigen Therapeutics was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA.

Similar to: United-Guardian, Inc., GW Pharmaceuticals Plc, Sanofi

Featured Company


Nature Group Plc

St. Helier, JE, GB

NATURE GROUP is the market leader in handling Marpol and offshore waste, with more than 25 years’ collection and treatment experience.… Learn more →

You may also be interested in:


Sanofi

Paris, FR

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’… Learn more →

GW Pharmaceuticals Plc

Salisbury, WI, GB

GW Pharmaceuticals Plc researches and develops cannabinoid medicines. The companys principal activity is developing and manufacturing… Learn more →

United-Guardian, Inc.

Hauppauge, NY, US

United-Guardian, Inc. engages in the research, development, manufacture, and marketing of cosmetic ingredients, personal and health… Learn more →